New Drug Cuts Rare Disease Triglycerides by 32%
UK regulators just approved olezarsen, the first treatment in years for familial chylomicronemia syndrome, a rare genetic condition that can cause life-threatening pancreatic inflammation. Clinical trials showed patients reduced dangerous fat levels by a third while experiencing fewer emergency attacks.